Search by Drug Name or NDC

    NDC 66302-0114-01 Remodulin 8 mg/20mL Details

    Remodulin 8 mg/20mL

    Remodulin is a INTRAVENOUS; SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by United Therapeutics Corporation. The primary component is TREPROSTINIL.

    Product Information

    NDC 66302-0114
    Product ID 66302-114_a8994b40-f2ce-4a6d-bc58-8b5214231d5a
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Remodulin
    Proprietary Name Suffix n/a
    Non-Proprietary Name treprostinil
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS; SUBCUTANEOUS
    Active Ingredient Strength 8
    Active Ingredient Units mg/20mL
    Substance Name TREPROSTINIL
    Labeler Name United Therapeutics Corporation
    Pharmaceutical Class Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA021272
    Listing Certified Through 2024-12-31

    Package

    NDC 66302-0114-01 (66302011401)

    NDC Package Code 66302-114-01
    Billing NDC 66302011401
    Package 1 VIAL in 1 BOX (66302-114-01) / 20 mL in 1 VIAL
    Marketing Start Date 2023-09-28
    NDC Exclude Flag N
    Pricing Information N/A